Antiplatelet therapies educational programs

Showing 4 of 27

Acute Coronary Syndromes

Personalized PCI: Patient-Centered Care in Practice

Feb 3, 2012 13:22 EST

How to put evidence-based care into practice? Drs Skelding and Spertus compare 2 complementary systems used in their respective facilities.

Acute Coronary Syndromes

Cardiology Fellow X Factor: Case Contest

Jan 26, 2012 10:00 EST

Do you have an ACS case with the X Factor? We're looking for cases that include teaching points regarding the management of antiplatelet therapy in ACS. See if your case will pique the interest of our expert panel.

Acute Coronary Syndromes

The Late Night Report: Plato Medical Management

Dec 21, 2011 11:12 EST

Do medically managed patients get the same benefit from ticagrelor as invasively treated patients? Dr. Magnus Ohman queries Dr. Gabriel Steg for the answer.

Acute Coronary Syndromes

Testing the Trialists: Genetics and Platelet Function Testing in PCI: Can we ELEVATE our Practice?

3 COMMENTS - Dec 8, 2011 16:30 EST

Drs. Ohman, Gurbel, and Mega discuss the implications of the ELEVATE-TIMI 56 trial for patients who are poor responders to clopidogrel.

Acute Coronary Syndromes

TCT/AHA 2011: Antiplatelet Hot Topics

Dec 7, 2011 15:00 EST

ATLAS-ACS 2, BRIDGE, RAPID GENE, and TRACER are among the trials that Dr. Bhatt interviews Drs. Bonello, Mega, Kastrati, and Kleiman about.

Acute Coronary Syndromes

The Perfect Match: The Appropriate Antiplatelet Strategy for Patients Undergoing Primary PCI

Dec 7, 2011 09:20 EST

Dr. Bates outlines the management of 2 patients from presentation to follow-up including discussion of the 2011 updated PCI guidelines.

Acute Coronary Syndromes

Testing the Trialists: Secondary Prevention: A Global Perspective With Dr. Salim Yusuf

Nov 30, 2011 13:43 EST

Underuse of secondary prevention therapies for CVD is a global problem that needs to be fixed. Drs. Ohman and Yusuf discuss the strategies.

Acute Coronary Syndromes

Testing the Trialists: STEMI Care: The Forest and the Trees

Nov 28, 2011 09:45 EST

Where do we stand after 2 decades in STEMI care? Join Drs. Ohman and Stone for an insightful discussion.

Acute Coronary Syndromes

ACS Clinical Trials and Registries Using Antiplatelet Agents: Where Does the Truth Lie?

1 COMMENT - Nov 23, 2011 10:03 EST

Clinical trials and registries. Do we need both? Drs. Lopes and Peterson discuss how to interpret and apply the data in clinical practice.

Acute Coronary Syndromes

Switching Antiplatelet Therapies: Case-Based Guidance on the Use of Platelet Testing

Nov 22, 2011 14:43 EST

Hitting the sweet spot for antiplatelet efficacy. Is platelet reactivity the answer? Drs. Lopes and Becker explore the possibilities.

Acute Coronary Syndromes

Late Night Report: PCI With Stents and Atrial Fibrillation: Dual vs Triple Antithrombotic Therapy

1 COMMENT - Oct 24, 2011 12:10 EDT

How to select the best antithrombotic strategy for patients with AF undergoing coronary stenting? Drs. Ohman and Becker discuss.

Acute Coronary Syndromes

Antiplatelets in ACS: Expanding Choices

Oct 21, 2011 16:00 EDT

With the recent approval of a third P2Y₁₂ inhibitor, how should new agents be integrated into practice? Dr. Storey leads a case-based discussion with Drs. Geisler, Mehta, and Wiviott.

Interventional/Surgery

Stable Ischemic Heart Disease: Navigating the Decision to Intervene

Oct 3, 2011 13:44 EDT

When is it appropriate to revascularize patients with stable ischemic heart disease? Dr. King walks through 2 typical cases outlining the data behind his decision-making.

Acute Coronary Syndromes

NSTEMI Guidelines: Are the US and Europe in Harmony?

Sep 29, 2011 11:00 EDT

Dr. White asks Drs. Ohman and Fox about the similarities and differences between the 2 sets of guidelines.

Acute Coronary Syndromes

Testing the Trialist: Addressing the Platelet in ACS and PCI

Sep 21, 2011 09:41 EDT

Drs. Ohman and Angiolillo discuss the impact of aspirin maintenance dosage during P2Y₁₂ inhibition on clinical outcome and the clinical significance of the observed change in on-clopidogrel platelet reactivity over time after PCI.

Acute Coronary Syndromes

Antiplatelet Therapy in the Elderly Patient With ACS

Sep 14, 2011 10:50 EDT

Dr. Adam Skolnick reviews the data on how to manage elderly patients with ACS, focusing on antiplatelet and antithrombotic strategies.

Acute Coronary Syndromes

Antiplatelet Strategies in Acute Coronary Syndrome

Aug 30, 2011 14:18 EDT

Antiplatelet options in ACS are expanding across the globe. Dr. Abizaid from Brazil and Dr. Gaxiola from Mexico discuss 2 ACS cases and the data behind their decision-making.

Acute Coronary Syndromes

Antiplatelet Resistance: Does It Matter?

3 COMMENTS - Jun 22, 2011 15:32 EDT

GRAVITAS and the early cessation of TRIGGER-PCI left many wondering if testing antiplatelet response is worth it. Drs. ten Berg and Collet discuss the practical application of all the data.

Acute Coronary Syndromes

Antiplatelet Therapy: Summer Polling Questions

1 COMMENT - May 19, 2011 14:28 EDT

Have GRAVITAS and RIVAL affected your use of platelet function testing and transradial access? How often do you use glycoprotein IIb/IIIa inhibitors? Answer our polling questions and learn what your colleagues do.

Acute Coronary Syndromes

Antiplatelet Therapy in ACS Patients With Prior Stroke

1 COMMENT - May 12, 2011 12:30 EDT

Dr. Wiviott leads a discussion with Dr. Mahaffey and neurologist Dr. Alberts on fine tuning therapy in this high-risk cohort.

Acute Coronary Syndromes

Antiplatelet Therapy in the ACS Patient Undergoing CABG

Apr 28, 2011 10:26 EDT

Surgeon Dr. Puskas and interventionalist Dr. Fox discuss bridging strategies and thienopyridine discontinuation as well as the ACC late-breaking STICH and RAPS trials.

Acute Coronary Syndromes

Individualized Antiplatelet Therapy in Practice

Mar 21, 2011 11:38 EDT

Dr. Mahmud explains the role of platelet function and genomic testing in tailoring oral antiplatelet therapy.

Acute Coronary Syndromes

ACS - Series of Rapid Responses to Emerging Questions

2 COMMENTS - Oct 6, 2010 14:00 EDT

Click here for both The Late Night Report and Testing the Trialists series with Dr Magnus Ohman.

Acute Coronary Syndromes

Proton Pump Inhibitors and Dual Antiplatelet Therapy: Myths and Reality

3 COMMENTS - Jul 30, 2010 10:53 EDT

Do PPIs affect thienopyridine efficacy? The data so far are conflicting. Dr. Gilles Montalescot provides insights from a new meta-analysis.

Acute Coronary Syndromes

Antiplatelet Therapy: Point-of-Care Testing 101

1 COMMENT - Jul 21, 2010 09:53 EDT

Drs. Storey, Kereiakes, and Montalescot discuss the use of point-of-care testing to assess antiplatelet responsiveness, including strategies for treating poor responders.

Acute Coronary Syndromes

Minimizing the Risk for Stent Thrombosis

4 COMMENTS - Jul 8, 2010 13:37 EDT

Dr. Gershlick quizzes Dr. Collet regarding his stent-thrombosis prevention strategies and his thoughts on trials such as GRAVITAS and DAPT.

Acute Coronary Syndromes

Tailoring Oral Antiplatelet Therapy in ACS Patients Undergoing PCI

Jul 8, 2010 12:57 EDT

POPULAR PI Dr. ten Berg discusses the practicalities of using genetics and platelet-response assays to optimize antiplatelet therapy.

CME provider: Medscape, LLC.

	No
	Yes

What's New